Bioretec Oy risk profile
73 Stretched several inputs deteriorating together
Measured 21 October 2026 from BRETEC's filed statements. Recomputed nightly.
73 (Stretched), driven by Cash conversion at 100, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | Reads pct_below_52w_high, volatility_1y_pct and avg_turnover_90d_usd. No reading is stored for this company. | |||
| Operating pressure | 82 | Acute | Worsening | Costs outgrowing revenue — +62.1 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.06x |
| Leverage and coverage | 35 | Normal | Stable | Interest cover — -6.39x |
| Competitive position | 73 | Stretched | Stable | Operating-margin gap against peers — -201.4 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.